Biotechnology
The Biotechnology industry has a total of 678 stocks, with a combined market cap of $1,463.72 billion and total revenue of $121.74 billion.
Market Cap
1,463.72B
Revenue
121.74B
Profits
-33.35B
PE Ratio
n/a
Profit Margin
-27.39%
Dividend Yield
0.09%
678 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 586.51B | -0.86% | 2,355,834 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 115.03B | 1.04% | 809,247 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 106.25B | 1.48% | 289,146 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 50.89B | 0.17% | 2,184,717 | 5.15B |
| 5 | ARGX | argenx SE | 21.79B | -2.87% | 92,300 | 39.48M |
| 6 | BNTX | BioNTech SE | 21.60B | -2.55% | 391,593 | 2.97B |
| 7 | GMAB | Genmab A/S | 19.52B | 1.11% | 201,869 | 2.57B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.90B | -1.20% | 267,201 | 2.00B |
| 9 | BGNE | BeiGene, Ltd. | 18.57B | 1.06% | 241,937 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 14.74B | 0.77% | 2,846,974 | 2.47B |
| 11 | TECH | Bio-Techne Corporation | 13.20B | 1.16% | 1,060,562 | 1.15B |
| 12 | INCY | Incyte Corporation | 12.84B | 0.42% | 1,064,779 | 3.77B |
| 13 | SRPT | Sarepta Therapeutics, Inc. | 12.42B | -1.02% | 685,333 | 1.40B |
| 14 | RPRX | Royalty Pharma plc | 12.31B | -2.19% | 1,512,649 | 2.24B |
| 15 | UTHR | United Therapeutics Corporation | 12.15B | 0.75% | 192,146 | 2.50B |
| 16 | ROIV | Roivant Sciences Ltd. | 9.05B | -1.58% | 3,088,400 | 123.24M |
| 17 | LEGN | Legend Biotech Corporation | 8.24B | -2.61% | 459,855 | 342.80M |
| 18 | PCVX | Vaxcyte, Inc. | 8.08B | -1.17% | 456,526 | - |
| 19 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.68B | -0.59% | 929,429 | - |
| 20 | VKTX | Viking Therapeutics, Inc. | 7.36B | -2.98% | 3,821,108 | - |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 6.86B | -1.36% | 425,533 | 3.84B |
| 22 | ASND | Ascendis Pharma A/S | 6.83B | -1.37% | 504,929 | 357.63M |
| 23 | BPMC | Blueprint Medicines Corporation | 6.55B | -1.58% | 257,111 | 282.21M |
| 24 | RVMD | Revolution Medicines, Inc. | 6.47B | 1.08% | 608,866 | 4.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 6.25B | -0.65% | 740,136 | 3.75M |
| 26 | EXEL | Exelixis, Inc. | 6.08B | -1.51% | 1,065,913 | 1.85B |
| 27 | HALO | Halozyme Therapeutics, Inc. | 5.68B | -1.50% | 700,994 | 862.99M |
| 28 | BBIO | BridgeBio Pharma, Inc. | 5.61B | -3.06% | 1,681,433 | 218.60M |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 5.42B | -0.82% | 994,682 | 776.62M |
| 30 | IBRX | ImmunityBio, Inc. | 5.30B | -1.29% | 3,917,667 | 302.00K |
| 31 | APLS | Apellis Pharmaceuticals, Inc. | 5.03B | -1.64% | 642,088 | 524.07M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.76B | 0.99% | 826,598 | 271.71M |
| 33 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.70B | 1.33% | 171,409 | - |
| 34 | KRYS | Krystal Biotech, Inc. | 4.68B | 0.20% | 125,541 | 95.95M |
| 35 | NUVL | Nuvalent, Inc. | 4.57B | -2.42% | 238,545 | - |
| 36 | ALPN | Alpine Immune Sciences, Inc. | 4.46B | 0.02% | 1,213,394 | 56.52M |
| 37 | IMVT | Immunovant, Inc. | 4.44B | -2.48% | 463,522 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.06B | -0.98% | 431,168 | 1.97M |
| 39 | INSM | Insmed Incorporated | 3.66B | -1.31% | 905,586 | 315.49M |
| 40 | AXSM | Axsome Therapeutics, Inc. | 3.64B | -1.05% | 379,089 | 251.02M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.49B | -1.74% | 566,754 | 442.59M |
| 42 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.31B | -2.81% | 537,017 | - |
| 43 | SWTX | SpringWorks Therapeutics, Inc. | 3.30B | 0.16% | 431,984 | 26.45M |
| 44 | SMMT | Summit Therapeutics Inc. | 3.13B | -1.55% | 765,523 | - |
| 45 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.09B | -0.92% | 425,097 | 35.47M |
| 46 | IDYA | IDEAYA Biosciences, Inc. | 3.06B | -2.48% | 543,627 | 15.50M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 3.01B | -1.34% | 147,691 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 2.95B | -6.40% | 287,960 | - |
| 49 | DNLI | Denali Therapeutics Inc. | 2.93B | 1.33% | 406,363 | 295.39M |
| 50 | CORT | Corcept Therapeutics Incorporated | 2.92B | 2.00% | 589,604 | 523.53M |
| 51 | IOVA | Iovance Biotherapeutics, Inc. | 2.87B | -1.82% | 3,583,727 | 1.90M |
| 52 | ACLX | Arcellx, Inc. | 2.87B | 1.57% | 321,621 | 131.66M |
| 53 | FOLD | Amicus Therapeutics, Inc. | 2.84B | 0.74% | 1,358,639 | 423.49M |
| 54 | RNA | Avidity Biosciences, Inc. | 2.82B | 2.72% | 673,397 | 10.87M |
| 55 | MOR | MorphoSys AG | 2.77B | -1.76% | 439,497 | 264.75M |
| 56 | IMCR | Immunocore Holdings plc | 2.67B | -1.77% | 738,872 | 264.25M |
| 57 | MRUS | Merus N.V. | 2.59B | -2.47% | 406,645 | 38.34M |
| 58 | TGTX | TG Therapeutics, Inc. | 2.54B | -5.40% | 2,570,203 | 289.33M |
| 59 | PTCT | PTC Therapeutics, Inc. | 2.54B | -2.75% | 388,327 | 927.56M |
| 60 | NTLA | Intellia Therapeutics, Inc. | 2.53B | 0.19% | 818,849 | 52.60M |
| 61 | CLDX | Celldex Therapeutics, Inc. | 2.52B | -4.33% | 305,626 | 6.07M |
| 62 | MLTX | MoonLake Immunotherapeutics | 2.50B | -2.72% | 241,467 | - |
| 63 | FTRE | Fortrea Holdings Inc. | 2.46B | -0.93% | 1,133,374 | 3.11B |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 2.46B | -0.40% | 980,157 | 813.81M |
| 65 | JANX | Janux Therapeutics, Inc. | 2.45B | -0.86% | 432,250 | 7.29M |
| 66 | VCEL | Vericel Corporation | 2.35B | 1.55% | 198,594 | 207.78M |
| 67 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.29B | -3.09% | 388,808 | 91.93M |
| 68 | VERA | Vera Therapeutics, Inc. | 2.27B | -1.31% | 239,238 | - |
| 69 | GERN | Geron Corporation | 2.25B | -2.31% | 5,018,709 | 520.00K |
| 70 | RXRX | Recursion Pharmaceuticals, Inc. | 2.25B | -0.95% | 3,893,808 | 46.24M |
| 71 | ARVN | Arvinas, Inc. | 2.25B | 1.78% | 400,202 | 71.30M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.24B | -3.72% | 1,069,501 | - |
| 73 | KYMR | Kymera Therapeutics, Inc. | 2.16B | -1.83% | 335,004 | 79.41M |
| 74 | ADMA | ADMA Biologics, Inc. | 2.13B | 1.66% | 2,853,865 | 283.18M |
| 75 | RCKT | Rocket Pharmaceuticals, Inc. | 2.05B | -3.33% | 340,830 | - |
| 76 | BEAM | Beam Therapeutics Inc. | 2.03B | 3.49% | 604,756 | 360.91M |
| 77 | CGON | CG Oncology, Inc. | 1.99B | -3.20% | 527,993 | 539.00K |
| 78 | GLPG | Galapagos NV | 1.95B | 0.27% | 126,232 | - |
| 79 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -1.89% | 367,171 | 29.40M |
| 80 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.95B | 0.55% | 658,526 | 411.35M |
| 81 | SANA | Sana Biotechnology, Inc. | 1.94B | 2.11% | 847,763 | - |
| 82 | ZLAB | Zai Lab Limited | 1.92B | -2.66% | 322,226 | 291.07M |
| 83 | KROS | Keros Therapeutics, Inc. | 1.88B | -3.17% | 209,462 | 234.00K |
| 84 | NVAX | Novavax, Inc. | 1.84B | -9.65% | 12,243,638 | 996.61M |
| 85 | ARDX | Ardelyx, Inc. | 1.83B | 0.26% | 1,559,296 | 159.11M |
| 86 | FUSN | Fusion Pharmaceuticals Inc. | 1.83B | 0.23% | 150,055 | 2.04M |
| 87 | INBX | Inhibrx, Inc. | 1.82B | 0.61% | 604,299 | 1.78M |
| 88 | PTGX | Protagonist Therapeutics, Inc. | 1.80B | -3.76% | 261,997 | 314.95M |
| 89 | NAMS | NewAmsterdam Pharma Company N.V. | 1.80B | 0.20% | 131,960 | - |
| 90 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.78B | -3.98% | 29,913,219 | 208.70M |
| 91 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -3.01% | 625,306 | - |
| 92 | KURA | Kura Oncology, Inc. | 1.70B | -3.52% | 348,388 | - |
| 93 | GPCR | Structure Therapeutics Inc. | 1.69B | 0.75% | 374,152 | - |
| 94 | EWTX | Edgewise Therapeutics, Inc. | 1.69B | -0.39% | 381,626 | - |
| 95 | SLNO | Soleno Therapeutics, Inc. | 1.68B | 1.10% | 261,776 | - |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | -0.96% | 239,950 | 617.51M |
| 97 | LGND | Ligand Pharmaceuticals Incorporated | 1.55B | 1.22% | 71,665 | 118.31M |
| 98 | NMRA | Neumora Therapeutics, Inc. | 1.54B | 0.42% | 265,564 | - |
| 99 | RCUS | Arcus Biosciences, Inc. | 1.54B | -3.21% | 255,013 | 237.00M |
| 100 | SYRE | Spyre Therapeutics, Inc. | 1.53B | - | 268,690 | 688.00K |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.50B | 1.98% | 1,263,277 | 274.10M |
| 102 | MORF | Morphic Holding, Inc. | 1.47B | -9.92% | 269,572 | - |
| 103 | TARS | Tarsus Pharmaceuticals, Inc. | 1.45B | -0.88% | 293,489 | 42.56M |
| 104 | XNCR | Xencor, Inc. | 1.42B | 2.54% | 450,721 | 162.18M |
| 105 | DAWN | Day One Biopharmaceuticals, Inc. | 1.41B | 0.87% | 238,472 | - |
| 106 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.40B | -1.69% | 147,144 | 301.77M |
| 107 | AKRO | Akero Therapeutics, Inc. | 1.38B | -3.91% | 247,862 | - |
| 108 | CGEM | Cullinan Oncology, Inc. | 1.33B | -2.69% | 640,266 | - |
| 109 | BLTE | Belite Bio, Inc | 1.33B | 5.96% | 102,555 | - |
| 110 | VIR | Vir Biotechnology, Inc. | 1.31B | -2.01% | 349,638 | 79.60M |
| 111 | FDMT | 4D Molecular Therapeutics, Inc. | 1.31B | -1.17% | 289,354 | 20.45M |
| 112 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.29B | -2.94% | 2,732,487 | 355.40M |
| 113 | MNKD | MannKind Corporation | 1.25B | - | 1,499,046 | 224.60M |
| 114 | PRTA | Prothena Corporation plc | 1.21B | -3.72% | 237,189 | 89.25M |
| 115 | GYRE | Gyre Therapeutics, Inc. | 1.21B | -6.87% | 59,533 | 140.62M |
| 116 | MDXG | MiMedx Group, Inc. | 1.15B | -1.14% | 328,024 | 334.51M |
| 117 | MIRM | Mirum Pharmaceuticals, Inc. | 1.13B | -2.75% | 135,966 | 224.00M |
| 118 | IMTX | Immatics N.V. | 1.12B | 1.39% | 224,769 | 80.95M |
| 119 | SAVA | Cassava Sciences, Inc. | 1.11B | 7.24% | 688,109 | - |
| 120 | PHVS | Pharvaris N.V. | 1.10B | -6.26% | 23,158 | - |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.08B | -3.23% | 145,421 | - |
| 122 | ARQT | Arcutis Biotherapeutics, Inc. | 1.07B | 0.88% | 2,702,113 | 106.39M |
| 123 | ABCL | AbCellera Biologics Inc. | 1.07B | -3.70% | 926,203 | 35.79M |
| 124 | VRNA | Verona Pharma plc | 1.06B | -2.69% | 947,693 | - |
| 125 | SLN | Silence Therapeutics plc | 1.04B | 0.26% | 105,275 | 33.86M |
| 126 | INVA | Innoviva, Inc. | 997.87M | - | 279,266 | 311.59M |
| 127 | NRIX | Nurix Therapeutics, Inc. | 983.19M | 7.73% | 2,758,567 | 80.89M |
| 128 | SRRK | Scholar Rock Holding Corporation | 974.60M | -12.78% | 1,612,637 | - |
| 129 | LQDA | Liquidia Corporation | 970.06M | -0.24% | 513,292 | 15.97M |
| 130 | OCUL | Ocular Therapeutix, Inc. | 959.54M | -1.59% | 919,044 | 59.84M |
| 131 | TYRA | Tyra Biosciences, Inc. | 958.71M | -4.40% | 91,473 | - |
| 132 | PROK | ProKidney Corp. | 933.93M | 6.99% | 475,671 | - |
| 133 | PLRX | Pliant Therapeutics, Inc. | 921.17M | -2.18% | 302,070 | 248.00K |
| 134 | BCYC | Bicycle Therapeutics plc | 915.75M | -3.70% | 99,668 | 41.61M |
| 135 | CNTA | Centessa Pharmaceuticals plc | 889.27M | -0.89% | 59,168 | 6.85M |
| 136 | RLAY | Relay Therapeutics, Inc. | 881.41M | 2.00% | 1,131,471 | 35.33M |
| 137 | SPRY | ARS Pharmaceuticals, Inc. | 875.93M | -0.77% | 166,651 | 10.00K |
| 138 | ABVX | Abivax SA | 869.52M | -2.57% | 15,570 | 5.13M |
| 139 | ZNTL | Zentalis Pharmaceuticals, Inc. | 858.19M | 0.92% | 301,723 | 40.56M |
| 140 | VRDN | Viridian Therapeutics, Inc. | 857.46M | -8.07% | 860,663 | 288.00K |
| 141 | PRME | Prime Medicine, Inc. | 852.22M | 0.57% | 528,298 | 591.00K |
| 142 | ETNB | 89bio, Inc. | 850.04M | -3.79% | 400,482 | - |
| 143 | MESO | Mesoblast Limited | 838.81M | 4.70% | 175,816 | 7.25M |
| 144 | IMNM | Immunome, Inc. | 828.17M | -3.96% | 594,686 | 12.68M |
| 145 | AUPH | Aurinia Pharmaceuticals Inc. | 825.22M | -0.17% | 1,923,441 | 191.41M |
| 146 | NUVB | Nuvation Bio Inc. | 820.61M | -2.64% | 620,774 | - |
| 147 | LBPH | Longboard Pharmaceuticals, Inc. | 807.35M | 0.88% | 133,901 | - |
| 148 | ARCT | Arcturus Therapeutics Holdings Inc. | 800.14M | -2.36% | 226,114 | 124.53M |
| 149 | TNGX | Tango Therapeutics, Inc. | 799.21M | -3.47% | 263,196 | 37.23M |
| 150 | IRON | Disc Medicine, Inc. | 796.53M | 0.81% | 163,919 | - |
| 151 | CRGX | CARGO Therapeutics, Inc. | 796.23M | -4.31% | 100,551 | - |
| 152 | RGNX | REGENXBIO Inc. | 785.68M | -0.12% | 181,831 | 86.73M |
| 153 | HLVX | HilleVax, Inc. | 784.10M | 1.73% | 77,239 | - |
| 154 | CVAC | CureVac N.V. | 783.59M | 0.29% | 2,246,629 | 59.73M |
| 155 | PRTC | PureTech Health plc | 775.57M | 4.01% | 3,041 | 3.33M |
| 156 | WVE | Wave Life Sciences Ltd. | 774.07M | 6.10% | 763,285 | 112.91M |
| 157 | PRAX | Praxis Precision Medicines, Inc. | 771.91M | 0.40% | 234,006 | 2.20M |
| 158 | HUMA | Humacyte, Inc. | 753.80M | -1.40% | 3,414,399 | - |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 752.08M | -2.36% | 71,754 | 2.26M |
| 160 | AUTL | Autolus Therapeutics plc | 743.90M | 7.86% | 1,906,706 | 10.50M |
| 161 | ALXO | ALX Oncology Holdings Inc. | 737.74M | -3.07% | 137,235 | - |
| 162 | STOK | Stoke Therapeutics, Inc. | 725.51M | -0.93% | 368,486 | 7.85M |
| 163 | COGT | Cogent Biosciences, Inc. | 717.58M | -0.40% | 414,927 | - |
| 164 | SAGE | Sage Therapeutics, Inc. | 704.73M | -2.58% | 663,429 | 91.06M |
| 165 | LYEL | Lyell Immunopharma, Inc. | 692.16M | -1.44% | 922,582 | 68.00K |
| 166 | ANAB | AnaptysBio, Inc. | 687.34M | -1.57% | 92,258 | 22.96M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 677.58M | -0.25% | 53,561 | - |
| 168 | KYTX | Kyverna Therapeutics, Inc. | 667.21M | 1.11% | 239,658 | - |
| 169 | EXAI | Exscientia plc | 656.17M | 1.36% | 587,061 | 25.42M |
| 170 | ITOS | iTeos Therapeutics, Inc. | 651.30M | 0.84% | 266,125 | - |
| 171 | GHRS | GH Research PLC | 647.23M | -1.02% | 40,768 | - |
| 172 | ZYME | Zymeworks Inc. | 644.12M | -2.77% | 214,579 | 50.46M |
| 173 | MLYS | Mineralys Therapeutics, Inc. | 641.96M | -1.14% | 28,922 | - |
| 174 | SVRA | Savara Inc. | 633.60M | -5.08% | 411,339 | - |
| 175 | PHAR | Pharming Group N.V. | 626.30M | -0.53% | 1,089 | 280.83M |
| 176 | ORIC | ORIC Pharmaceuticals, Inc. | 620.62M | 1.55% | 258,686 | - |
| 177 | PHAT | Phathom Pharmaceuticals, Inc. | 618.13M | -1.40% | 418,387 | 2.59M |
| 178 | EYPT | EyePoint Pharmaceuticals, Inc. | 616.68M | -5.43% | 715,867 | 50.02M |
| 179 | VALN | Valneva SE | 605.68M | 0.79% | 11,402 | 166.26M |
| 180 | CABA | Cabaletta Bio, Inc. | 595.25M | -2.14% | 700,770 | - |
| 181 | AVTE | Aerovate Therapeutics, Inc. | 591.43M | -6.12% | 113,369 | - |
| 182 | CALT | Calliditas Therapeutics AB (publ) | 588.25M | 1.32% | 699 | 119.73M |
| 183 | MNMD | Mind Medicine (MindMed) Inc. | 583.75M | -4.97% | 856,591 | - |
| 184 | CDMO | Avid Bioservices, Inc. | 577.35M | -0.87% | 1,516,898 | 136.74M |
| 185 | TSHA | Taysha Gene Therapies, Inc. | 576.95M | -1.59% | 861,756 | 14.16M |
| 186 | ENGN | enGene Holdings Inc. | 572.88M | -8.53% | 4,772 | - |
| 187 | ALT | Altimmune, Inc. | 566.15M | -10.00% | 3,094,832 | 410.00K |
| 188 | ABUS | Arbutus Biopharma Corporation | 561.43M | 3.11% | 643,651 | 12.99M |
| 189 | THRD | Third Harmonic Bio, Inc. | 561.22M | -2.57% | 40,617 | - |
| 190 | OLMA | Olema Pharmaceuticals, Inc. | 551.23M | 1.86% | 351,776 | - |
| 191 | IGMS | IGM Biosciences, Inc. | 541.25M | -0.75% | 64,943 | 2.11M |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 532.00M | -2.96% | 1,351,192 | 174.50M |
| 193 | ATXS | Astria Therapeutics, Inc. | 525.52M | 1.17% | 163,594 | - |
| 194 | ALEC | Alector, Inc. | 521.92M | -0.91% | 380,115 | 96.41M |
| 195 | ABSI | Absci Corporation | 520.75M | -2.64% | 462,440 | 5.35M |
| 196 | OABI | OmniAb, Inc. | 519.45M | -2.20% | 335,555 | 21.05M |
| 197 | CBUS | Cibus, Inc. | 512.91M | 0.71% | 20,973 | 2.32M |
| 198 | CELC | Celcuity Inc. | 510.39M | -5.10% | 153,351 | - |
| 199 | YMAB | Y-mAbs Therapeutics, Inc. | 509.48M | -2.11% | 303,140 | 84.50M |
| 200 | TRDA | Entrada Therapeutics, Inc. | 506.38M | 0.27% | 80,826 | 162.87M |
| 201 | KALV | KalVista Pharmaceuticals, Inc. | 503.31M | -1.24% | 283,470 | - |
| 202 | OCGN | Ocugen, Inc. | 488.92M | -3.54% | 5,902,752 | 7.05M |
| 203 | HRTX | Heron Therapeutics, Inc. | 485.86M | -0.62% | 2,930,716 | 132.10M |
| 204 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 482.83M | -2.00% | 106,065 | - |
| 205 | APLT | Applied Therapeutics, Inc. | 478.21M | -1.41% | 513,475 | -477.00K |
| 206 | ALLO | Allogene Therapeutics, Inc. | 475.83M | -7.97% | 1,774,987 | 65.00K |
| 207 | TCRX | TScan Therapeutics, Inc. | 474.18M | 0.90% | 141,185 | 14.81M |
| 208 | URGN | UroGen Pharma Ltd. | 474.03M | 0.08% | 186,797 | 84.30M |
| 209 | VERV | Verve Therapeutics, Inc. | 470.90M | -6.27% | 1,729,789 | 16.05M |
| 210 | FULC | Fulcrum Therapeutics, Inc. | 469.88M | -3.14% | 297,049 | 2.51M |
| 211 | LRMR | Larimar Therapeutics, Inc. | 468.93M | -0.67% | 207,659 | - |
| 212 | RNAC | Cartesian Therapeutics, Inc. | 468.75M | 0.34% | 20,809 | 25.91M |
| 213 | EDIT | Editas Medicine, Inc. | 461.77M | -4.58% | 1,125,057 | 69.41M |
| 214 | TVTX | Travere Therapeutics, Inc. | 460.96M | -9.42% | 833,656 | 183.23M |
| 215 | NKTX | Nkarta, Inc. | 459.45M | -4.25% | 390,516 | - |
| 216 | VYGR | Voyager Therapeutics, Inc. | 458.81M | -2.32% | 395,046 | 119.04M |
| 217 | LXEO | Lexeo Therapeutics, Inc. | 456.29M | -1.21% | 41,839 | - |
| 218 | TBPH | Theravance Biopharma, Inc. | 447.45M | -3.23% | 178,509 | 61.51M |
| 219 | MREO | Mereo BioPharma Group plc | 446.06M | -2.14% | 398,879 | - |
| 220 | FATE | Fate Therapeutics, Inc. | 442.78M | -5.80% | 876,828 | 6.48M |
| 221 | KRRO | Korro Bio, Inc. | 441.01M | 6.63% | 53,832 | - |
| 222 | BMEA | Biomea Fusion, Inc. | 440.32M | -4.23% | 321,481 | - |
| 223 | OCS | Oculis Holding AG | 439.97M | -0.79% | 3,697 | 995.46K |
| 224 | LXRX | Lexicon Pharmaceuticals, Inc. | 437.07M | -3.80% | 1,705,077 | 2.31M |
| 225 | SLRN | Acelyrin, Inc. | 434.23M | -5.18% | 588,148 | - |
| 226 | PEPG | PepGen Inc. | 430.82M | -3.59% | 24,889 | - |
| 227 | NGNE | Neurogene Inc. | 428.54M | -1.22% | 37,751 | - |
| 228 | LENZ | LENZ Therapeutics, Inc. | 416.71M | -1.09% | 152,099 | - |
| 229 | ADCT | ADC Therapeutics SA | 401.74M | 0.24% | 326,367 | 68.62M |
| 230 | ANNX | Annexon, Inc. | 396.47M | -0.69% | 1,235,576 | - |
| 231 | REPL | Replimune Group, Inc. | 394.11M | -4.17% | 552,238 | - |
| 232 | CCCC | C4 Therapeutics, Inc. | 389.44M | -4.86% | 813,934 | 20.04M |
| 233 | CTNM | Contineum Therapeutics, Inc. | 388.27M | 3.61% | 57,331 | 50.00M |
| 234 | AVXL | Anavex Life Sciences Corp. | 385.12M | 1.11% | 602,218 | - |
| 235 | TRML | Tourmaline Bio, Inc. | 384.57M | 0.27% | 155,981 | - |
| 236 | TERN | Terns Pharmaceuticals, Inc. | 382.89M | -3.91% | 284,949 | - |
| 237 | STTK | Shattuck Labs, Inc. | 375.41M | 0.96% | 448,379 | 2.72M |
| 238 | FBLG | FibroBiologics, Inc. | 371.03M | -3.81% | 48,744 | - |
| 239 | NAUT | Nautilus Biotechnology, Inc. | 369.53M | 1.03% | 76,390 | - |
| 240 | VRCA | Verrica Pharmaceuticals Inc. | 368.21M | -5.25% | 136,917 | 8.91M |
| 241 | MGTX | MeiraGTx Holdings plc | 367.83M | 0.53% | 51,701 | 697.00K |
| 242 | QTTB | Q32 Bio Inc. | 366.38M | -2.06% | 49,789 | 354.00K |
| 243 | TNYA | Tenaya Therapeutics, Inc. | 365.11M | 9.65% | 572,480 | - |
| 244 | AURA | Aura Biosciences, Inc. | 355.72M | 0.97% | 172,314 | - |
| 245 | IMMP | Immutep Limited | 354.28M | 1.37% | 114,670 | 4.58M |
| 246 | PGEN | Precigen, Inc. | 353.39M | -1.43% | 446,187 | 5.44M |
| 247 | JSPR | Jasper Therapeutics, Inc. | 347.42M | 0.77% | 61,116 | - |
| 248 | SLDB | Solid Biosciences Inc. | 343.50M | -3.76% | 190,915 | - |
| 249 | CADL | Candel Therapeutics, Inc. | 342.06M | -9.45% | 791,759 | - |
| 250 | SKYE | Skye Bioscience, Inc. | 339.62M | -1.63% | 19,833 | - |
| 251 | NBTX | Nanobiotix S.A. | 338.73M | -0.28% | 1,253 | 40.23M |
| 252 | ERAS | Erasca, Inc. | 338.05M | 6.49% | 7,706,197 | - |
| 253 | MRSN | Mersana Therapeutics, Inc. | 334.66M | 5.81% | 2,027,816 | 38.30M |
| 254 | VTYX | Ventyx Biosciences, Inc. | 334.17M | -5.02% | 374,106 | - |
| 255 | ANRO | Alto Neuroscience, Inc. | 333.50M | -2.73% | 69,819 | - |
| 256 | STRO | Sutro Biopharma, Inc. | 328.40M | -3.37% | 336,097 | 154.07M |
| 257 | GUTS | Fractyl Health, Inc. | 327.14M | 5.53% | 247,180 | 148.00K |
| 258 | NKTR | Nektar Therapeutics | 322.26M | -2.50% | 903,258 | 90.17M |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 319.51M | -1.79% | 670,223 | 177.60M |
| 260 | ACIU | AC Immune SA | 318.12M | -6.74% | 526,271 | 16.82M |
| 261 | RVNC | Revance Therapeutics, Inc. | 317.00M | -4.43% | 1,892,321 | 236.65M |
| 262 | INO | Inovio Pharmaceuticals, Inc. | 311.71M | -6.18% | 387,901 | 717.07K |
| 263 | PSTX | Poseida Therapeutics, Inc. | 310.26M | -4.63% | 439,941 | 82.50M |
| 264 | AVIR | Atea Pharmaceuticals, Inc. | 308.26M | -1.35% | 256,280 | - |
| 265 | CRBU | Caribou Biosciences, Inc. | 307.07M | -5.57% | 2,199,641 | 33.40M |
| 266 | XOMA | XOMA Corporation | 299.00M | -0.58% | 4,531 | 5.81M |
| 267 | XERS | Xeris Biopharma Holdings, Inc. | 292.06M | -1.98% | 1,112,256 | 171.36M |
| 268 | ATNM | Actinium Pharmaceuticals, Inc. | 289.33M | -0.51% | 169,968 | 81.00K |
| 269 | VSTM | Verastem, Inc. | 288.08M | -5.19% | 122,287 | - |
| 270 | IVVD | Invivyd, Inc. | 287.55M | -2.04% | 280,728 | - |
| 271 | ATAI | Atai Life Sciences N.V. | 286.28M | -8.06% | 2,266,645 | 277.00K |
| 272 | INZY | Inozyme Pharma, Inc. | 284.84M | -2.75% | 204,899 | - |
| 273 | ADAP | Adaptimmune Therapeutics plc | 283.60M | -7.50% | 980,504 | 18.36M |
| 274 | OPT | Opthea Limited | 281.69M | -1.73% | 7,224 | 385.28K |
| 275 | CRMD | CorMedix Inc. | 281.39M | -1.54% | 408,210 | - |
| 276 | BDTX | Black Diamond Therapeutics, Inc. | 276.20M | -7.06% | 1,157,996 | - |
| 277 | MGNX | MacroGenics, Inc. | 274.34M | -14.75% | 3,125,992 | 43.36M |
| 278 | ACRV | Acrivon Therapeutics, Inc. | 273.26M | 3.86% | 48,110 | - |
| 279 | MGX | Metagenomi, Inc. | 263.43M | - | 21,944 | 47.26M |
| 280 | RANI | Rani Therapeutics Holdings, Inc. | 263.19M | -4.40% | 110,073 | - |
| 281 | CYBN | Cybin Inc. | 262.63M | -0.57% | 1,912,143 | - |
| 282 | ZURA | Zura Bio Limited | 262.10M | 0.83% | 410,656 | - |
| 283 | GLUE | Monte Rosa Therapeutics, Inc. | 261.65M | -0.38% | 125,540 | 1.06M |
| 284 | EPIX | ESSA Pharma Inc. | 258.19M | -8.80% | 21,802 | - |
| 285 | ENTA | Enanta Pharmaceuticals, Inc. | 257.97M | -7.12% | 220,000 | 72.88M |
| 286 | XBIT | XBiotech Inc. | 255.39M | -1.75% | 22,833 | - |
| 287 | QSI | Quantum-Si incorporated | 255.27M | -3.23% | 247,577 | 1.29M |
| 288 | CDXS | Codexis, Inc. | 254.71M | -4.24% | 372,631 | 74.23M |
| 289 | IPSC | Century Therapeutics, Inc. | 251.86M | -3.83% | 57,890 | 1.37M |
| 290 | DSGN | Design Therapeutics, Inc. | 249.71M | -2.00% | 97,117 | - |
| 291 | CDXC | ChromaDex Corporation | 246.38M | -5.17% | 238,801 | 83.17M |
| 292 | TSVT | 2seventy bio, Inc. | 245.97M | -4.00% | 194,113 | 71.20M |
| 293 | PYXS | Pyxis Oncology, Inc. | 243.80M | -0.48% | 230,971 | 16.15M |
| 294 | QURE | uniQure N.V. | 243.72M | -1.18% | 312,728 | 19.00M |
| 295 | CHRS | Coherus BioSciences, Inc. | 242.65M | -2.30% | 1,226,646 | 301.87M |
| 296 | GBIO | Generation Bio Co. | 242.16M | -2.92% | 67,146 | 9.96M |
| 297 | AKBA | Akebia Therapeutics, Inc. | 242.08M | 0.88% | 2,172,491 | 187.23M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 235.92M | -5.16% | 50,992 | 33.90M |
| 299 | GTHX | G1 Therapeutics, Inc. | 235.53M | -3.21% | 510,863 | 84.04M |
| 300 | ALDX | Aldeyra Therapeutics, Inc. | 234.46M | -3.42% | 177,041 | - |
| 301 | AGEN | Agenus Inc. | 228.68M | 3.43% | 364,323 | 161.42M |
| 302 | ELYM | Eliem Therapeutics, Inc. | 228.44M | 0.86% | 291,621 | - |
| 303 | ANL | Adlai Nortye Ltd. | 226.29M | -4.81% | 1,462 | 5.00M |
| 304 | OVID | Ovid Therapeutics Inc. | 223.48M | -3.82% | 66,795 | 473.54K |
| 305 | PRLD | Prelude Therapeutics Incorporated | 222.46M | -6.54% | 34,977 | - |
| 306 | CMPX | Compass Therapeutics, Inc. | 220.14M | - | 139,829 | - |
| 307 | MACK | Merrimack Pharmaceuticals, Inc. | 220.01M | - | 840,045 | - |
| 308 | IPHA | Innate Pharma S.A. | 219.07M | 5.44% | 12,265 | 68.49M |
| 309 | ABOS | Acumen Pharmaceuticals, Inc. | 218.84M | -2.14% | 64,306 | - |
| 310 | BOLD | Boundless Bio, Inc. | 218.32M | -2.91% | 75,781 | - |
| 311 | INMB | INmune Bio, Inc. | 216.82M | -2.86% | 75,744 | 131.00K |
| 312 | CLLS | Cellectis S.A. | 213.82M | -1.32% | 26,907 | 9.19M |
| 313 | HOWL | Werewolf Therapeutics, Inc. | 208.15M | -3.28% | 104,455 | 16.22M |
| 314 | CDT | Conduit Pharmaceuticals Inc. | 207.46M | 1.02% | 24,665 | - |
| 315 | LCTX | Lineage Cell Therapeutics, Inc. | 203.90M | 1.89% | 1,300,615 | 8.00M |
| 316 | GALT | Galectin Therapeutics Inc. | 199.89M | 2.87% | 135,179 | - |
| 317 | OMER | Omeros Corporation | 199.62M | 4.23% | 330,493 | - |
| 318 | IVA | Inventiva S.A. | 198.70M | 2.82% | 7,296 | 25.74M |
| 319 | BLUE | bluebird bio, Inc. | 198.52M | -1.90% | 1,571,954 | 21.73M |
| 320 | ELEV | Elevation Oncology, Inc. | 197.79M | - | 144,632 | - |
| 321 | PBYI | Puma Biotechnology, Inc. | 197.78M | -7.14% | 1,407,050 | 226.63M |
| 322 | CRVO | CervoMed Inc. | 197.35M | -1.11% | 19,407 | 6.36M |
| 323 | CAPR | Capricor Therapeutics, Inc. | 197.23M | 9.93% | 676,310 | 27.10M |
| 324 | ZVRA | Zevra Therapeutics, Inc. | 197.13M | -0.63% | 114,894 | 28.01M |
| 325 | ATOS | Atossa Therapeutics, Inc. | 196.81M | -2.48% | 753,610 | - |
| 326 | TRVI | Trevi Therapeutics, Inc. | 195.11M | -2.46% | 50,961 | - |
| 327 | VERU | Veru Inc. | 193.23M | -3.65% | 1,455,949 | 13.48M |
| 328 | DRTS | Alpha Tau Medical Ltd. | 192.29M | 7.60% | 112,269 | - |
| 329 | FENC | Fennec Pharmaceuticals Inc. | 192.07M | -1.12% | 272,022 | 44.95M |
| 330 | CGEN | Compugen Ltd. | 188.01M | -1.40% | 190,075 | 33.46M |
| 331 | GNFT | Genfit S.A. | 186.88M | -1.08% | 6,403 | 42.42M |
| 332 | YS | YS Biopharma Co., Ltd. | 184.56M | 2.94% | 55,566 | - |
| 333 | ABEO | Abeona Therapeutics Inc. | 183.28M | -4.35% | 412,201 | 3.50M |
| 334 | GLSI | Greenwich LifeSciences, Inc. | 182.74M | -3.25% | 13,533 | - |
| 335 | OTLK | Outlook Therapeutics, Inc. | 181.51M | 6.14% | 165,938 | - |
| 336 | OBIO | Orchestra BioMed Holdings, Inc. | 180.73M | 12.77% | 30,533 | 2.22M |
| 337 | TELO | Telomir Pharmaceuticals, Inc. | 179.14M | -2.29% | 20,030 | - |
| 338 | KOD | Kodiak Sciences Inc. | 172.80M | -11.76% | 390,696 | - |
| 339 | ACHV | Achieve Life Sciences, Inc. | 171.02M | -1.38% | 95,427 | - |
| 340 | SCPH | scPharmaceuticals Inc. | 170.54M | -1.55% | 192,375 | 17.63M |
| 341 | VXRT | Vaxart, Inc. | 169.92M | -6.00% | 1,415,148 | 8.89M |
| 342 | ADVM | Adverum Biotechnologies, Inc. | 169.48M | -2.55% | 1,582,900 | - |
| 343 | RIGL | Rigel Pharmaceuticals, Inc. | 167.14M | -3.27% | 342,914 | 120.35M |
| 344 | CRDF | Cardiff Oncology, Inc. | 163.69M | -2.94% | 490,008 | 610.00K |
| 345 | MDWD | MediWound Ltd. | 160.88M | -1.79% | 27,016 | 18.69M |
| 346 | GOSS | Gossamer Bio, Inc. | 159.17M | -4.93% | 787,307 | - |
| 347 | PRQR | ProQR Therapeutics N.V. | 156.79M | 1.04% | 62,512 | 14.66M |
| 348 | XFOR | X4 Pharmaceuticals, Inc. | 156.05M | -3.26% | 1,801,404 | - |
| 349 | RPTX | Repare Therapeutics Inc. | 151.11M | 0.57% | 190,868 | 97.86M |
| 350 | CNTX | Context Therapeutics Inc. | 150.00M | 11.11% | 602,086 | - |
| 351 | CTMX | CytomX Therapeutics, Inc. | 149.99M | -5.50% | 2,966,365 | 119.18M |
| 352 | SGMT | Sagimet Biosciences Inc. | 147.28M | -2.74% | 245,842 | 2.00M |
| 353 | SYRS | Syros Pharmaceuticals, Inc. | 145.91M | -0.55% | 147,304 | 6.98M |
| 354 | CRVS | Corvus Pharmaceuticals, Inc. | 143.24M | 4.57% | 230,843 | - |
| 355 | RAPT | RAPT Therapeutics, Inc. | 141.01M | -2.42% | 428,572 | - |
| 356 | MCRB | Seres Therapeutics, Inc. | 139.38M | -0.49% | 1,848,220 | 126.85M |
| 357 | LIFE | aTyr Pharma, Inc. | 138.02M | 3.63% | 553,837 | 588.00K |
| 358 | SGMO | Sangamo Therapeutics, Inc. | 137.79M | 6.72% | 4,723,061 | 18.76M |
| 359 | DBVT | DBV Technologies S.A. | 137.60M | -1.25% | 109,588 | 14.94M |
| 360 | BCAB | BioAtla, Inc. | 136.89M | -8.71% | 488,383 | - |
| 361 | RENB | Renovaro Biosciences Inc. | 136.53M | 5.75% | 142,862 | - |
| 362 | TVGN | Tevogen Bio Holdings Inc. | 136.25M | -7.87% | 412,311 | - |
| 363 | SEER | Seer, Inc. | 135.39M | -0.47% | 276,539 | 15.67M |
| 364 | KPTI | Karyopharm Therapeutics Inc. | 135.37M | 1.32% | 1,448,320 | 140.46M |
| 365 | IMAB | I-Mab | 134.79M | -1.13% | 266,189 | 3.90M |
| 366 | ACET | Adicet Bio, Inc. | 133.12M | 1.91% | 914,529 | - |
| 367 | VIGL | Vigil Neuroscience, Inc. | 131.92M | -0.56% | 40,387 | - |
| 368 | OMGA | Omega Therapeutics, Inc. | 131.82M | 1.26% | 226,213 | 4.94M |
| 369 | RGLS | Regulus Therapeutics Inc. | 130.93M | - | 247,157 | - |
| 370 | PDSB | PDS Biotechnology Corporation | 128.19M | -1.13% | 211,374 | - |
| 371 | ALLK | Allakos Inc. | 127.95M | -0.69% | 342,674 | - |
| 372 | COYA | Coya Therapeutics, Inc. | 126.45M | 2.71% | 43,551 | 6.13M |
| 373 | MOLN | Molecular Partners AG | 125.43M | 0.67% | 523 | 7.64M |
| 374 | AMLX | Amylyx Pharmaceuticals, Inc. | 124.79M | - | 967,117 | 398.00M |
| 375 | VOR | Vor Biopharma Inc. | 122.87M | 0.56% | 146,993 | - |
| 376 | DMAC | DiaMedica Therapeutics Inc. | 121.19M | - | 5,841 | - |
| 377 | VTGN | VistaGen Therapeutics, Inc. | 120.67M | -2.42% | 69,705 | 1.04M |
| 378 | FGEN | FibroGen, Inc. | 119.87M | -3.23% | 1,154,369 | 167.49M |
| 379 | CLRB | Cellectar Biosciences, Inc. | 118.70M | -0.90% | 604,239 | - |
| 380 | CTXR | Citius Pharmaceuticals, Inc. | 118.32M | -2.86% | 795,004 | - |
| 381 | IMUX | Immunic, Inc. | 113.19M | -0.40% | 1,372,902 | - |
| 382 | NVCT | Nuvectis Pharma, Inc. | 112.34M | -5.82% | 101,176 | - |
| 383 | ADAG | Adagene Inc. | 109.41M | 4.51% | 7,395 | 18.11M |
| 384 | VANI | Vivani Medical, Inc. | 109.41M | 1.27% | 144,508 | - |
| 385 | PMVP | PMV Pharmaceuticals, Inc. | 107.77M | -2.33% | 168,451 | - |
| 386 | RZLT | Rezolute, Inc. | 105.33M | 3.13% | 206,055 | - |
| 387 | BYSI | BeyondSpring Inc. | 104.76M | -5.64% | 41,220 | 1.75M |
| 388 | EPRX | Eupraxia Pharmaceuticals Inc. | 104.73M | -0.34% | 2,413 | - |
| 389 | ELTX | Elicio Therapeutics, Inc. | 102.52M | 7.14% | 48,963 | - |
| 390 | LPTX | Leap Therapeutics, Inc. | 102.27M | -4.01% | 357,907 | - |
| 391 | RLMD | Relmada Therapeutics, Inc. | 101.08M | -4.30% | 41,789 | - |
| 392 | GNLX | Genelux Corporation | 100.16M | 1.39% | 37,240 | 8.00K |
| 393 | CLSD | Clearside Biomedical, Inc. | 99.39M | - | 203,555 | 8.45M |
| 394 | ARMP | Armata Pharmaceuticals, Inc. | 97.62M | -2.26% | 21,116 | 4.70M |
| 395 | CNTB | Connect Biopharma Holdings Limited | 97.26M | 1.42% | 51,383 | - |
| 396 | ATHA | Athira Pharma, Inc. | 95.82M | -7.01% | 153,887 | - |
| 397 | IFRX | InflaRx N.V. | 94.21M | 12.41% | 464,695 | 107.75K |
| 398 | ORMP | Oramed Pharmaceuticals Inc. | 93.85M | -1.29% | 41,390 | 674.00K |
| 399 | MIST | Milestone Pharmaceuticals Inc. | 92.94M | -0.57% | 247,432 | - |
| 400 | BRNS | Barinthus Biotherapeutics plc | 91.54M | -3.29% | 328 | 334.00K |
| 401 | IOBT | IO Biotech, Inc. | 90.92M | -1.43% | 49,860 | - |
| 402 | ANIX | Anixa Biosciences, Inc. | 90.60M | -2.06% | 68,839 | 210.00K |
| 403 | ALVR | AlloVir, Inc. | 89.70M | 3.19% | 138,870 | - |
| 404 | ANVS | Annovis Bio, Inc. | 89.48M | 3.49% | 389,577 | - |
| 405 | CMRX | Chimerix, Inc. | 88.93M | 1.83% | 83,324 | 41.00K |
| 406 | BNTC | Benitec Biopharma Inc. | 88.62M | 0.21% | 23,852 | 7.00K |
| 407 | ENTX | Entera Bio Ltd. | 87.32M | -6.15% | 69,159 | - |
| 408 | GRTS | Gritstone bio, Inc. | 86.72M | 5.46% | 1,770,474 | 15.65M |
| 409 | DTIL | Precision BioSciences, Inc. | 85.46M | 3.51% | 36,089 | 57.53M |
| 410 | SPRO | Spero Therapeutics, Inc. | 85.42M | 1.27% | 168,507 | 110.98M |
| 411 | SLS | SELLAS Life Sciences Group, Inc. | 84.90M | -0.68% | 1,037,410 | - |
| 412 | PLX | Protalix BioTherapeutics, Inc. | 83.95M | -2.56% | 161,494 | 59.65M |
| 413 | ONCY | Oncolytics Biotech Inc. | 83.34M | -1.77% | 260,727 | - |
| 414 | PASG | Passage Bio, Inc. | 83.21M | -1.49% | 35,884 | - |
| 415 | CUE | Cue Biopharma, Inc. | 82.69M | -1.72% | 89,661 | 7.02M |
| 416 | ALRN | Aileron Therapeutics, Inc. | 82.04M | -2.08% | 16,799 | - |
| 417 | ASMB | Assembly Biosciences, Inc. | 81.79M | -1.29% | 5,049 | - |
| 418 | HOOK | HOOKIPA Pharma Inc. | 81.00M | 0.54% | 260,885 | 53.55M |
| 419 | AFMD | Affimed N.V. | 79.95M | -3.49% | 24,460 | 9.19M |
| 420 | CGTX | Cognition Therapeutics, Inc. | 78.53M | 1.03% | 49,681 | - |
| 421 | BTAI | BioXcel Therapeutics, Inc. | 77.50M | -0.96% | 837,288 | 1.76M |
| 422 | TIL | Instil Bio, Inc. | 76.68M | -2.54% | 493 | - |
| 423 | JAGX | Jaguar Health, Inc. | 74.82M | -9.84% | 22,122,002 | 10.14M |
| 424 | TLSA | Tiziana Life Sciences Ltd | 74.66M | 4.94% | 108,203 | - |
| 425 | ATRA | Atara Biotherapeutics, Inc. | 73.45M | 1.06% | 1,722,199 | 34.70M |
| 426 | RLYB | Rallybio Corporation | 73.37M | -4.84% | 160,918 | - |
| 427 | MRNS | Marinus Pharmaceuticals, Inc. | 73.34M | 2.31% | 1,094,626 | 28.29M |
| 428 | SER | Serina Therapeutics Inc | 73.20M | 5.85% | 4,676 | 3.15M |
| 429 | ELDN | Eledon Pharmaceuticals, Inc. | 72.96M | 7.86% | 580,427 | - |
| 430 | CLGN | CollPlant Biotechnologies Ltd. | 72.16M | -0.94% | 2,222 | 10.96M |
| 431 | MAIA | MAIA Biotechnology, Inc. | 72.06M | 6.09% | 416,351 | - |
| 432 | TPST | Tempest Therapeutics, Inc. | 70.54M | -1.24% | 308,698 | - |
| 433 | LVTX | LAVA Therapeutics N.V. | 70.45M | -4.09% | 39,846 | 7.52M |
| 434 | MNOV | MediciNova, Inc. | 70.39M | -0.70% | 6,703 | 1.00M |
| 435 | LABP | Landos Biopharma, Inc. | 70.24M | - | 12,544 | - |
| 436 | CRIS | Curis, Inc. | 69.84M | -6.35% | 25,083 | 9.81M |
| 437 | CVM | CEL-SCI Corporation | 69.36M | -9.29% | 365,284 | - |
| 438 | IKNA | Ikena Oncology, Inc. | 68.53M | 2.14% | 153,198 | 3.85M |
| 439 | INTS | Intensity Therapeutics, Inc. | 68.42M | -4.12% | 52,250 | - |
| 440 | VTVT | vTv Therapeutics Inc. | 67.83M | 0.07% | 5,550 | 1.00M |
| 441 | ANTX | AN2 Therapeutics, Inc. | 67.71M | - | 51,494 | - |
| 442 | CKPT | Checkpoint Therapeutics, Inc. | 67.24M | 5.62% | 464,706 | 68.00K |
| 443 | CELU | Celularity Inc. | 65.87M | -1.64% | 31,364 | 14.79M |
| 444 | LTRN | Lantern Pharma Inc. | 65.52M | -1.79% | 42,149 | - |
| 445 | TARA | Protara Therapeutics, Inc. | 64.86M | -17.38% | 768,774 | - |
| 446 | CSBR | Champions Oncology, Inc. | 64.71M | - | 2,302 | 49.22M |
| 447 | IMMX | Immix Biopharma, Inc. | 64.45M | 9.78% | 93,406 | - |
| 448 | MURA | Mural Oncology plc | 63.80M | -3.34% | 80,111 | - |
| 449 | AVRO | AVROBIO, Inc. | 62.63M | - | 530,942 | - |
| 450 | TSBX | Turnstone Biologics Corp. | 62.10M | -2.56% | 99,176 | 19.31M |
| 451 | KRON | Kronos Bio, Inc. | 61.30M | 3.89% | 241,434 | 7.59M |
| 452 | OCEA | Ocean Biomedical, Inc. | 60.64M | 3.53% | 134,687 | - |
| 453 | GNTA | Genenta Science S.p.A. | 60.12M | - | 1,650 | - |
| 454 | ANEB | Anebulo Pharmaceuticals, Inc. | 59.64M | 4.55% | 7,121 | - |
| 455 | AEON | AEON Biopharma, Inc. | 59.09M | 2.00% | 64,345 | - |
| 456 | THTX | Theratechnologies Inc. | 58.62M | 1.54% | 20,861 | 57.85M |
| 457 | RPHM | Reneo Pharmaceuticals, Inc. | 58.49M | 5.42% | 166,088 | - |
| 458 | CARM | Carisma Therapeutics, Inc. | 58.16M | 2.92% | 203,050 | 15.07M |
| 459 | EQ | Equillium, Inc. | 56.05M | 1.30% | 27,152 | 37.89M |
| 460 | KZR | Kezar Life Sciences, Inc. | 55.86M | -0.30% | 209,180 | 7.00M |
| 461 | CDTX | Cidara Therapeutics, Inc. | 53.14M | -6.58% | 59,308 | 46.38M |
| 462 | BLRX | BioLineRx Ltd. | 52.97M | -0.30% | 301,089 | 4.80M |
| 463 | ALGS | Aligos Therapeutics, Inc. | 51.63M | 5.11% | 869,695 | 13.79M |
| 464 | DYAI | Dyadic International, Inc. | 50.29M | -0.60% | 19,385 | 2.26M |
| 465 | DARE | Daré Bioscience, Inc. | 49.33M | 11.61% | 902,947 | 2.82M |
| 466 | OKYO | OKYO Pharma Limited | 48.56M | -1.94% | 11,769 | - |
| 467 | NTRB | Nutriband Inc. | 48.38M | -5.30% | 40,580 | 2.09M |
| 468 | CLNN | Clene Inc. | 48.03M | -4.05% | 271,312 | 620.00K |
| 469 | ABIO | ARCA biopharma, Inc. | 47.95M | -16.75% | 439,807 | - |
| 470 | AADI | Aadi Bioscience, Inc. | 46.90M | -0.26% | 69,233 | 23.84M |
| 471 | GANX | Gain Therapeutics, Inc. | 46.89M | -2.23% | 55,060 | - |
| 472 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 46.48M | -2.34% | 281,738 | - |
| 473 | NXTC | NextCure, Inc. | 46.44M | 1.21% | 82,300 | - |
| 474 | MLEC | Moolec Science SA | 46.20M | - | 40,860 | 2.90M |
| 475 | INAB | IN8bio, Inc. | 45.45M | 0.98% | 36,043 | - |
| 476 | CTCX | Carmell Therapeutics Corporation | 45.19M | -0.97% | 22,256 | 21.92M |
| 477 | CASI | CASI Pharmaceuticals, Inc. | 44.29M | 0.30% | 15,407 | 33.88M |
| 478 | OCUP | Ocuphire Pharma, Inc. | 43.81M | -2.88% | 104,977 | 19.01M |
| 479 | IMRX | Immuneering Corporation | 43.65M | -4.55% | 162,715 | - |
| 480 | MTNB | Matinas BioPharma Holdings, Inc. | 43.19M | -1.73% | 1,393,339 | - |
| 481 | XLO | Xilio Therapeutics, Inc. | 42.45M | 5.56% | 105,798 | - |
| 482 | HCWB | HCW Biologics Inc. | 41.98M | - | 13,965 | 1.16M |
| 483 | LEXX | Lexaria Bioscience Corp. | 41.36M | 0.32% | 261,309 | 386.00K |
| 484 | CARA | Cara Therapeutics, Inc. | 41.04M | -6.84% | 224,216 | 16.94M |
| 485 | VYNE | VYNE Therapeutics Inc. | 40.82M | 2.59% | 31,903 | 423.00K |
| 486 | EYEN | Eyenovia, Inc. | 40.40M | -8.65% | 950,927 | 8.78K |
| 487 | UNCY | Unicycive Therapeutics, Inc. | 39.49M | 0.97% | 215,172 | - |
| 488 | QNCX | Quince Therapeutics, Inc. | 38.89M | -1.62% | 166,209 | - |
| 489 | ACHL | Achilles Therapeutics plc | 38.40M | 1.03% | 114,355 | - |
| 490 | SNSE | Sensei Biotherapeutics, Inc. | 38.37M | -3.77% | 170,780 | - |
| 491 | ESLA | Estrella Immunopharma, Inc. | 38.07M | -1.46% | 24,322 | - |
| 492 | NRXP | NRx Pharmaceuticals, Inc. | 37.77M | 0.57% | 195,917 | - |
| 493 | ICCC | ImmuCell Corporation | 37.58M | -0.82% | 26,553 | 21.28M |
| 494 | IGC | IGC Pharma Inc | 37.42M | -6.01% | 795,026 | 1.22M |
| 495 | FBIO | Fortress Biotech, Inc. | 37.31M | 9.66% | 311,129 | 85.11M |
| 496 | MRKR | Marker Therapeutics, Inc. | 37.26M | 2.22% | 7,013 | 3.32M |
| 497 | BCLI | Brainstorm Cell Therapeutics Inc. | 37.14M | 0.79% | 692,238 | - |
| 498 | ACXP | Acurx Pharmaceuticals, Inc. | 35.66M | 3.21% | 36,528 | - |
| 499 | INKT | MiNK Therapeutics, Inc. | 35.60M | -2.88% | 64,417 | - |
| 500 | PMN | ProMIS Neurosciences, Inc. | 34.98M | -0.27% | 7,729 | - |
| 501 | RNXT | RenovoRx, Inc. | 34.29M | -3.52% | 27,371 | - |
| 502 | SABS | SAB Biotherapeutics, Inc. | 34.13M | -4.47% | 11,496 | 2.24M |
| 503 | EVGN | Evogene Ltd. | 32.88M | 1.88% | 68,386 | 5.64M |
| 504 | PLUR | Pluri Inc. | 32.79M | -0.33% | 11,760 | 341.00K |
| 505 | PTN | Palatin Technologies, Inc. | 32.60M | -1.96% | 92,437 | 5.90M |
| 506 | LPCN | Lipocine Inc. | 32.57M | 5.23% | 47,958 | 4.71M |
| 507 | VIRX | Viracta Therapeutics, Inc. | 32.20M | -0.38% | 67,406 | - |
| 508 | IPA | ImmunoPrecise Antibodies Ltd. | 31.31M | 6.31% | 182,811 | 17.67M |
| 509 | SPRB | Spruce Biosciences, Inc. | 30.62M | -2.58% | 586,924 | 10.13M |
| 510 | BOLT | Bolt Biotherapeutics, Inc. | 30.42M | -3.90% | 563,052 | 11.32M |
| 511 | BIVI | BioVie Inc. | 29.92M | -1.42% | 209,934 | - |
| 512 | SRZN | Surrozen, Inc. | 29.78M | -3.63% | 7,473 | - |
| 513 | APLM | Apollomics, Inc. | 29.73M | -2.29% | 103,841 | - |
| 514 | ICU | SeaStar Medical Holding Corporation | 29.13M | -3.91% | 998,831 | - |
| 515 | APRE | Aprea Therapeutics, Inc. | 28.62M | -3.48% | 7,767 | 963.80K |
| 516 | ONCT | Oncternal Therapeutics, Inc. | 26.48M | -1.93% | 3,864 | 1.15M |
| 517 | BIOR | Biora Therapeutics, Inc. | 26.44M | -1.03% | 205,405 | 544.00K |
| 518 | ENLV | Enlivex Therapeutics Ltd. | 26.22M | 0.71% | 41,336 | - |
| 519 | NKGN | NKGen Biotech, Inc. | 25.64M | -0.88% | 44,350 | - |
| 520 | ACST | Acasti Pharma Inc. | 25.28M | -2.18% | 14,851 | - |
| 521 | APM | Aptorum Group Limited | 25.13M | -6.86% | 23,480 | 431.38K |
| 522 | UBX | Unity Biotechnology, Inc. | 24.87M | 0.68% | 51,295 | - |
| 523 | GDTC | CytoMed Therapeutics Limited | 24.58M | -0.47% | 5,161 | - |
| 524 | NNVC | NanoViricides, Inc. | 24.40M | -7.17% | 219,586 | - |
| 525 | LYRA | Lyra Therapeutics, Inc. | 23.46M | 4.19% | 5,417,601 | 1.68M |
| 526 | ITRM | Iterum Therapeutics plc | 23.18M | -4.73% | 164,131 | - |
| 527 | NRBO | NeuroBo Pharmaceuticals, Inc. | 23.06M | 2.19% | 10,633 | - |
| 528 | LSTA | Lisata Therapeutics, Inc. | 22.93M | 1.47% | 8,598 | - |
| 529 | FBRX | Forte Biosciences, Inc. | 22.78M | 0.48% | 32,236 | - |
| 530 | BCTX | BriaCell Therapeutics Corp. | 22.05M | -3.47% | 152,825 | - |
| 531 | MEIP | MEI Pharma, Inc. | 21.19M | 7.51% | 12,469 | 66.75M |
| 532 | AIM | AIM ImmunoTech Inc. | 21.18M | 3.33% | 248,953 | 193.00K |
| 533 | NRSN | NeuroSense Therapeutics Ltd. | 20.80M | 0.83% | 78,589 | - |
| 534 | LUMO | Lumos Pharma, Inc. | 20.70M | -2.68% | 7,180 | 1.53M |
| 535 | SLGL | Sol-Gel Technologies Ltd. | 20.68M | 1.46% | 48,014 | 1.55M |
| 536 | VINC | Vincerx Pharma, Inc. | 20.51M | -4.08% | 425,151 | - |
| 537 | COCP | Cocrystal Pharma, Inc. | 20.25M | - | 7,504 | - |
| 538 | INDP | Indaptus Therapeutics, Inc. | 19.72M | -0.86% | 5,788 | - |
| 539 | SYBX | Synlogic, Inc. | 19.55M | -1.79% | 8,794 | 3.21M |
| 540 | NRXS | NeurAxis, Inc. | 19.45M | -1.62% | 14,913 | 2.46M |
| 541 | EVAX | Evaxion Biotech A/S | 19.40M | -3.38% | 6,366 | 73.00K |
| 542 | GLYC | GlycoMimetics, Inc. | 19.31M | 6.51% | 2,529,066 | 10.00K |
| 543 | APTO | Aptose Biosciences Inc. | 19.25M | -0.42% | 88,374 | - |
| 544 | PHGE | BiomX Inc. | 19.19M | 2.64% | 146,511 | - |
| 545 | TNXP | Tonix Pharmaceuticals Holding Corp. | 18.92M | 8.59% | 6,561,464 | 10.25M |
| 546 | TCRT | Alaunos Therapeutics, Inc. | 18.73M | -4.92% | 26,692 | 5.00K |
| 547 | ORGS | Orgenesis Inc. | 18.57M | 3.99% | 50,720 | 530.00K |
| 548 | KALA | Kala Pharmaceuticals, Inc. | 18.31M | -1.95% | 1,695 | - |
| 549 | PMCB | PharmaCyte Biotech, Inc. | 18.27M | 0.96% | 2,318 | - |
| 550 | VBIV | VBI Vaccines Inc. | 18.07M | -3.02% | 139,580 | 9.41M |
| 551 | NERV | Minerva Neurosciences, Inc. | 17.76M | 0.40% | 1,376 | - |
| 552 | IBIO | iBio, Inc. | 17.42M | 9.39% | 321,245 | 50.00K |
| 553 | SNTI | Senti Biosciences, Inc. | 17.20M | 0.53% | 62,139 | 1.28M |
| 554 | GLTO | Galecto, Inc. | 17.07M | -1.41% | 43,155 | - |
| 555 | ATHE | Alterity Therapeutics Limited | 17.05M | 1.01% | 14,961 | - |
| 556 | CDIO | Cardio Diagnostics Holdings, Inc. | 16.56M | -12.99% | 638,655 | 32.99K |
| 557 | TRAW | Traws Pharma, Inc. | 16.45M | -0.25% | 52,292 | 226.00K |
| 558 | EDSA | Edesa Biotech, Inc. | 14.94M | 1.56% | 14,031 | - |
| 559 | XTLB | XTL Biopharmaceuticals Ltd. | 14.67M | 2.01% | 4,539 | - |
| 560 | KPRX | Kiora Pharmaceuticals, Inc. | 14.60M | -1.98% | 150,810 | 16.00M |
| 561 | PPBT | Purple Biotech Ltd. | 14.48M | 10.34% | 131,336 | - |
| 562 | IMRN | Immuron Limited | 14.03M | 1.75% | 3,494 | 2.43M |
| 563 | PIRS | Pieris Pharmaceuticals, Inc. | 13.60M | -1.17% | 4,104 | 40.93M |
| 564 | ONVO | Organovo Holdings, Inc. | 13.38M | -0.96% | 43,659 | 242.00K |
| 565 | IMNN | Imunon, Inc. | 13.32M | - | 11,107 | - |
| 566 | COEP | Coeptis Therapeutics, Inc. | 13.00M | -1.46% | 31,881 | - |
| 567 | ADXN | Addex Therapeutics Ltd | 12.78M | 1.03% | 5,614 | 1.96M |
| 568 | DOMH | Dominari Holdings Inc. | 12.70M | 3.40% | 4,501 | 3.41M |
| 569 | AKTX | Akari Therapeutics, Plc | 12.19M | -0.65% | 17,133 | - |
| 570 | CMMB | Chemomab Therapeutics Ltd. | 12.16M | -3.33% | 22,907 | - |
| 571 | CLDI | Calidi Biotherapeutics, Inc. | 11.97M | -5.99% | 204,751 | - |
| 572 | ELAB | Elevai Labs, Inc. | 11.87M | 4.63% | 143,471 | 2.18M |
| 573 | CANF | Can-Fite BioPharma Ltd. | 11.73M | 6.37% | 54,511 | 743.00K |
| 574 | MBRX | Moleculin Biotech, Inc. | 11.70M | - | 6,933 | - |
| 575 | ALLR | Allarity Therapeutics, Inc. | 11.35M | -5.02% | 3,779,031 | - |
| 576 | ABVC | ABVC BioPharma, Inc. | 11.35M | 0.94% | 110,600 | 152.43K |
| 577 | ERNA | Eterna Therapeutics Inc. | 11.20M | -1.48% | 12,431 | 115.00K |
| 578 | IKT | Inhibikase Therapeutics, Inc. | 11.17M | -1.70% | 43,079 | 195.98K |
| 579 | GRTX | Galera Therapeutics, Inc. | 10.82M | 0.36% | 968,907 | - |
| 580 | BCDA | BioCardia, Inc. | 10.71M | -1.04% | 63,508 | 468.00K |
| 581 | MNPR | Monopar Therapeutics Inc. | 10.68M | -0.34% | 36,996 | - |
| 582 | CHRO | Chromocell Therapeutics Corporation | 10.68M | -12.94% | 47,305 | - |
| 583 | OGEN | Oragenics, Inc. | 10.44M | 42.07% | 497,094 | 20.63K |
| 584 | AEZS | Aeterna Zentaris Inc. | 10.34M | -0.35% | 5,641 | 4.50M |
| 585 | AVTX | Avalo Therapeutics, Inc. | 10.32M | -0.52% | 54,526 | 1.45M |
| 586 | FRES | Fresh2 Group Ltd | 10.27M | 13.41% | 46,425 | 2.35M |
| 587 | BNOX | Bionomics Limited | 9.65M | -3.18% | 31,779 | 15.00K |
| 588 | MTEM | Molecular Templates, Inc. | 9.55M | - | 20,026 | 31.76M |
| 589 | PSTV | Plus Therapeutics, Inc. | 9.36M | -0.44% | 39,512 | 6.08M |
| 590 | NTBL | Notable Labs, Ltd. | 9.29M | -1.92% | 117,471 | 311.00K |
| 591 | EFTR | eFFECTOR Therapeutics, Inc. | 9.22M | -2.02% | 57,518 | - |
| 592 | BRTX | BioRestorative Therapies, Inc. | 8.76M | -5.80% | 65,831 | 145.80K |
| 593 | LGVN | Longeveron Inc. | 8.03M | -0.78% | 193,931 | 978.00K |
| 594 | ASLN | ASLAN Pharmaceuticals Limited | 7.92M | 2.00% | 174,350 | 12.00M |
| 595 | VCNX | Vaccinex, Inc. | 7.89M | 6.36% | 3,105 | 124.00K |
| 596 | KTRA | Kintara Therapeutics, Inc. | 7.81M | -1.45% | 13,472,351 | - |
| 597 | CYCN | Cyclerion Therapeutics, Inc. | 7.72M | -4.36% | 1,068 | - |
| 598 | TRVN | Trevena, Inc. | 7.68M | -0.61% | 27,091 | 3.14M |
| 599 | NCNA | NuCana plc | 7.54M | -3.51% | 19,918 | - |
| 600 | RNAZ | TransCode Therapeutics, Inc. | 7.46M | 29.97% | 3,819,510 | - |
| 601 | HEPA | Hepion Pharmaceuticals, Inc. | 7.25M | 4.84% | 27,059 | - |
| 602 | PYPD | PolyPid Ltd. | 7.14M | -0.80% | 9,226 | - |
| 603 | VIRI | Virios Therapeutics, Inc. | 7.13M | -8.96% | 112,449 | - |
| 604 | PULM | Pulmatrix, Inc. | 7.01M | -0.52% | 8,732 | 11.68M |
| 605 | TENX | Tenax Therapeutics, Inc. | 7.00M | -1.69% | 12,214 | - |
| 606 | KZIA | Kazia Therapeutics Limited | 6.97M | 0.43% | 37,430 | 15.65K |
| 607 | KTTA | Pasithea Therapeutics Corp. | 6.89M | -1.79% | 388 | - |
| 608 | TFFP | TFF Pharmaceuticals, Inc. | 6.69M | -4.42% | 14,672 | 885.72K |
| 609 | PTIX | Protagenic Therapeutics, Inc. | 6.65M | 10.30% | 4,786 | - |
| 610 | ENVB | Enveric Biosciences, Inc. | 6.59M | -6.67% | 187,569 | - |
| 611 | CVKD | Cadrenal Therapeutics, Inc. | 6.57M | -4.44% | 165,886 | - |
| 612 | TOVX | Theriva Biologics, Inc. | 6.56M | -0.88% | 32,686 | - |
| 613 | ADIL | Adial Pharmaceuticals, Inc. | 6.50M | 9.93% | 132,974 | - |
| 614 | NLSP | NLS Pharmaceutics AG | 6.28M | 9.77% | 857,963 | - |
| 615 | SNGX | Soligenix, Inc. | 6.17M | 0.67% | 144,996 | 699.21K |
| 616 | PALI | Palisade Bio, Inc. | 6.04M | -1.55% | 24,984 | - |
| 617 | ENTO | Entero Therapeutics Inc. | 5.99M | 0.68% | - | - |
| 618 | CELZ | Creative Medical Technology Holdings, Inc. | 5.86M | 2.30% | 1,811 | 9.00K |
| 619 | HOTH | Hoth Therapeutics, Inc. | 5.82M | -0.84% | 15,285 | - |
| 620 | TTNP | Titan Pharmaceuticals, Inc. | 5.80M | - | 11,754 | 87.00K |
| 621 | LIPO | Lipella Pharmaceuticals Inc. | 5.78M | -1.50% | 56,163 | 477.45K |
| 622 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.66M | 2.22% | 28,980 | 92.73K |
| 623 | PCSA | Processa Pharmaceuticals, Inc. | 5.63M | -2.00% | 32,176 | - |
| 624 | XBIO | Xenetic Biosciences, Inc. | 5.62M | 1.06% | 1,612 | 2.44M |
| 625 | SILO | Silo Pharma, Inc. | 5.55M | 8.65% | 50,178 | 72.10K |
| 626 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.36M | 2.07% | 4,038 | - |
| 627 | MYMD | MyMD Pharmaceuticals, Inc. | 5.36M | 4.91% | 16,253 | - |
| 628 | KA | Kineta, Inc. | 5.34M | -5.83% | 36,956 | 5.16M |
| 629 | GNPX | Genprex, Inc. | 5.31M | 4.08% | 21,795 | - |
| 630 | AZTR | Azitra, Inc. | 5.27M | -8.22% | 11,648,244 | 572.70K |
| 631 | SNPX | Synaptogenix, Inc. | 5.17M | -2.06% | 23,934 | - |
| 632 | PRTG | Portage Biotech Inc. | 5.07M | -1.69% | 153,965 | - |
| 633 | XRTX | XORTX Therapeutics Inc. | 5.00M | 2.88% | 7,080 | - |
| 634 | DRUG | Bright Minds Biosciences Inc. | 4.75M | 0.92% | 9,242 | - |
| 635 | ENSC | Ensysce Biosciences, Inc. | 4.70M | -0.95% | 129,710 | - |
| 636 | NEXI | NexImmune, Inc. | 4.61M | -1.88% | 4,270 | - |
| 637 | NBY | NovaBay Pharmaceuticals, Inc. | 4.50M | -1.17% | 133,041,835 | 14.23M |
| 638 | ARTL | Artelo Biosciences, Inc. | 4.49M | 5.97% | 23,393 | - |
| 639 | ALZN | Alzamend Neuro, Inc. | 4.47M | -2.37% | 30,056 | - |
| 640 | XCUR | Exicure, Inc. | 4.38M | -2.06% | 32,117 | 21.77M |
| 641 | GTBP | GT Biopharma, Inc. | 4.31M | -4.29% | 8,299 | - |
| 642 | THAR | Tharimmune, Inc. | 4.29M | -1.90% | 81,437 | - |
| 643 | SEEL | Seelos Therapeutics, Inc. | 4.13M | -18.80% | 228,709 | 1.97M |
| 644 | ADTX | Aditxt, Inc. | 4.02M | -0.99% | 17,555 | 645.18K |
| 645 | TCON | TRACON Pharmaceuticals, Inc. | 3.96M | -6.54% | 114,022 | 12.15M |
| 646 | GOVX | GeoVax Labs, Inc. | 3.92M | -2.30% | 24,961 | - |
| 647 | CMND | Clearmind Medicine Inc. | 3.90M | -5.43% | 194,802 | - |
| 648 | MBIO | Mustang Bio, Inc. | 3.88M | 3.97% | 178,030 | - |
| 649 | PHIO | Phio Pharmaceuticals Corp. | 3.72M | 3.50% | 273,790 | - |
| 650 | SCPX | Scorpius Holdings, Inc. | 3.71M | 3.40% | 66,027,759 | 6.99M |
| 651 | ATXI | Avenue Therapeutics, Inc. | 3.59M | 0.81% | 36,978 | - |
| 652 | TCBP | TC Biopharm (Holdings) Plc | 3.59M | -0.88% | 213,481 | - |
| 653 | CYTO | Altamira Therapeutics Ltd. | 3.49M | 2.63% | 20,006 | - |
| 654 | ZVSA | ZyVersa Therapeutics, Inc. | 3.47M | -7.67% | 93,191 | - |
| 655 | ONCO | Onconetix, Inc. | 3.43M | 10.64% | 15,633,508 | 58.47K |
| 656 | BPTH | Bio-Path Holdings, Inc. | 3.36M | -8.55% | 61,610 | - |
| 657 | CYCC | Cyclacel Pharmaceuticals, Inc. | 3.34M | -2.14% | 30,544 | 449.00K |
| 658 | APVO | Aptevo Therapeutics Inc. | 3.26M | 0.48% | 155,463 | - |
| 659 | REVB | Revelation Biosciences, Inc. | 3.26M | 8.60% | 25,085 | - |
| 660 | FNCH | Finch Therapeutics Group, Inc. | 3.21M | -0.51% | 8,203 | - |
| 661 | CING | Cingulate Inc. | 3.10M | 1.51% | 15,729 | - |
| 662 | SPRC | SciSparc Ltd. | 2.99M | 1.67% | 52,268 | 2.88M |
| 663 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.94M | -2.06% | 33,289 | - |
| 664 | SCNI | Scinai Immunotherapeutics Ltd. | 2.67M | - | 18,345 | - |
| 665 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.66M | 0.85% | 1,256,117 | 569.86K |
| 666 | GLMD | Galmed Pharmaceuticals Ltd. | 2.43M | 1.50% | 72,982 | - |
| 667 | SLRX | Salarius Pharmaceuticals, Inc. | 2.36M | 5.15% | 40,816 | - |
| 668 | CNSP | CNS Pharmaceuticals, Inc. | 2.34M | -3.51% | 191,746 | - |
| 669 | WINT | Windtree Therapeutics, Inc. | 2.28M | 4.23% | 7,302 | - |
| 670 | QLGN | Qualigen Therapeutics, Inc. | 2.04M | -2.20% | 147,051 | - |
| 671 | VRAX | Virax Biolabs Group Limited | 1.98M | 4.94% | 22,150 | 79.30K |
| 672 | DRMA | Dermata Therapeutics, Inc. | 1.94M | -14.46% | 51,720 | - |
| 673 | INM | InMed Pharmaceuticals Inc. | 1.79M | 7.24% | 2,118,430 | 5.63M |
| 674 | GRI | GRI Bio, Inc. | 1.60M | -1.56% | 238,966 | - |
| 675 | NBSE | NeuBase Therapeutics, Inc. | 1.42M | -1.56% | 97,744 | - |
| 676 | ATNF | 180 Life Sciences Corp. | 1.36M | -0.63% | 48,389 | - |
| 677 | VRPX | Virpax Pharmaceuticals, Inc. | 910.05K | -1.26% | 253,507 | - |
| 678 | BDRX | Biodexa Pharmaceuticals Plc | 268.27K | -4.44% | 469,295 | 482.28K |